News | March 11, 2022
Aurobindo Pharma trains its managers to be `future ready’
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Earlier today, the Foundation for the National Institutes of Health (FNIH) announced that Dr. Gerberding will become CEO of the FNIH on May 16
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Subscribe To Our Newsletter & Stay Updated
